O	0	8	Prostate	Prostate	NN	B-NP
O	8	9	-	-	HYPH	I-NP
O	9	17	specific	specific	JJ	I-NP
O	18	26	membrane	membrane	NN	I-NP
O	27	34	antigen	antigen	NN	I-NP
O	35	44	regulates	regulate	VBZ	B-VP
O	45	57	angiogenesis	angiogenesis	NN	B-NP
O	58	60	by	by	IN	B-PP
O	61	71	modulating	modulate	VBG	B-VP
O	72	80	integrin	integrin	NN	B-NP
O	81	87	signal	signal	NN	I-NP
O	88	100	transduction	transduction	NN	I-NP
O	100	101	.	.	.	O

O	102	105	The	The	DT	B-NP
B-Cellular_component	106	119	transmembrane	transmembrane	JJ	I-NP
O	120	129	peptidase	peptidase	NN	I-NP
O	130	138	prostate	prostate	NN	I-NP
O	138	139	-	-	HYPH	B-NP
O	139	147	specific	specific	JJ	I-NP
O	148	156	membrane	membrane	NN	I-NP
O	157	164	antigen	antigen	NN	I-NP
O	165	166	(	(	(	O
O	166	170	PSMA	PSMA	NN	B-NP
O	170	171	)	)	)	O
O	172	174	is	be	VBZ	B-VP
O	175	186	universally	universally	RB	I-VP
O	187	198	upregulated	upregulate	VBN	I-VP
O	199	201	in	in	IN	B-PP
O	202	205	the	the	DT	B-NP
B-Multi-tissue_structure	206	217	vasculature	vasculature	NN	I-NP
O	218	220	of	of	IN	B-PP
B-Cancer	221	226	solid	solid	JJ	B-NP
I-Cancer	227	233	tumors	tumor	NNS	I-NP
O	233	234	,	,	,	O
O	235	238	but	but	CC	O
O	239	242	its	its	PRP$	B-NP
O	243	253	functional	functional	JJ	I-NP
O	254	258	role	role	NN	I-NP
O	259	261	in	in	IN	B-PP
B-Cancer	262	267	tumor	tumor	NN	B-NP
O	268	280	angiogenesis	angiogenesis	NN	I-NP
O	281	284	has	have	VBZ	B-VP
O	285	288	not	not	RB	I-VP
O	289	293	been	be	VBN	I-VP
O	294	306	investigated	investigate	VBN	I-VP
O	306	307	.	.	.	O

O	308	312	Here	Here	RB	B-ADVP
O	313	315	we	we	PRP	B-NP
O	316	320	show	show	VBP	B-VP
O	321	325	that	that	IN	B-SBAR
O	326	338	angiogenesis	angiogenesis	NN	B-NP
O	339	341	is	be	VBZ	B-VP
O	342	350	severely	severely	RB	B-ADJP
O	351	359	impaired	impaired	JJ	I-ADJP
O	360	362	in	in	IN	B-PP
O	363	367	PSMA	PSMA	NN	B-NP
O	367	368	-	-	HYPH	B-NP
O	368	372	null	null	JJ	I-NP
O	373	380	animals	animal	NNS	I-NP
O	381	384	and	and	CC	O
O	385	389	that	that	IN	B-SBAR
O	390	394	this	this	DT	B-NP
O	395	405	angiogenic	angiogenic	JJ	I-NP
O	406	412	defect	defect	NN	I-NP
O	413	419	occurs	occur	VBZ	B-VP
O	420	422	at	at	IN	B-PP
O	423	426	the	the	DT	B-NP
O	427	432	level	level	NN	I-NP
O	433	435	of	of	IN	B-PP
B-Cell	436	447	endothelial	endothelial	JJ	B-NP
I-Cell	448	452	cell	cell	NN	I-NP
O	453	461	invasion	invasion	NN	I-NP
O	462	469	through	through	IN	B-PP
O	470	473	the	the	DT	B-NP
B-Cellular_component	474	487	extracellular	extracellular	JJ	I-NP
I-Cellular_component	488	494	matrix	matrix	NN	I-NP
I-Cellular_component	495	502	barrier	barrier	NN	I-NP
O	502	503	.	.	.	O

O	504	511	Because	Because	IN	B-SBAR
O	512	523	proteolytic	proteolytic	JJ	B-NP
O	524	535	degradation	degradation	NN	I-NP
O	536	538	of	of	IN	B-PP
O	539	542	the	the	DT	B-NP
B-Cellular_component	543	556	extracellular	extracellular	JJ	I-NP
I-Cellular_component	557	563	matrix	matrix	NN	I-NP
O	564	566	is	be	VBZ	B-VP
O	567	568	a	a	DT	B-NP
O	569	577	critical	critical	JJ	I-NP
O	578	587	component	component	NN	I-NP
O	588	590	of	of	IN	B-PP
B-Cell	591	602	endothelial	endothelial	JJ	B-NP
O	603	611	invasion	invasion	NN	I-NP
O	612	614	in	in	IN	B-PP
O	615	627	angiogenesis	angiogenesis	NN	B-NP
O	627	628	,	,	,	O
O	629	631	it	it	PRP	B-NP
O	632	634	is	be	VBZ	B-VP
O	635	642	logical	logical	JJ	B-ADJP
O	643	645	to	to	TO	B-VP
O	646	652	assume	assume	VB	I-VP
O	653	657	that	that	IN	B-SBAR
O	658	662	PSMA	PSMA	NN	B-NP
O	663	675	participates	participate	VBZ	B-VP
O	676	678	in	in	IN	B-PP
B-Cellular_component	679	685	matrix	matrix	NN	B-NP
O	686	697	degradation	degradation	NN	I-NP
O	697	698	.	.	.	O

O	699	706	However	However	RB	B-ADVP
O	706	707	,	,	,	O
O	708	710	we	we	PRP	B-NP
O	711	722	demonstrate	demonstrate	VBP	B-VP
O	723	724	a	a	DT	B-NP
O	725	730	novel	novel	JJ	I-NP
O	731	734	and	and	CC	I-NP
O	735	739	more	more	RBR	I-NP
O	740	747	complex	complex	JJ	I-NP
O	748	752	role	role	NN	I-NP
O	753	756	for	for	IN	B-PP
O	757	761	PSMA	PSMA	NN	B-NP
O	762	764	in	in	IN	B-PP
O	765	777	angiogenesis	angiogenesis	NN	B-NP
O	777	778	,	,	,	O
O	779	784	where	where	WRB	B-ADVP
O	785	787	it	it	PRP	B-NP
O	788	790	is	be	VBZ	B-VP
O	791	792	a	a	DT	B-NP
O	793	802	principal	principal	JJ	I-NP
O	803	812	component	component	NN	I-NP
O	813	815	of	of	IN	B-PP
O	816	817	a	a	DT	B-NP
O	818	828	regulatory	regulatory	JJ	I-NP
O	829	833	loop	loop	NN	I-NP
O	834	838	that	that	WDT	B-NP
O	839	841	is	be	VBZ	B-VP
O	842	849	tightly	tightly	RB	I-VP
O	850	860	modulating	modulate	VBG	I-VP
O	861	868	laminin	laminin	NN	B-NP
O	868	869	-	-	HYPH	B-NP
O	869	877	specific	specific	JJ	I-NP
O	878	886	integrin	integrin	NN	I-NP
O	887	896	signaling	signaling	NN	I-NP
O	897	900	and	and	CC	I-NP
O	901	907	GTPase	GTPase	NN	I-NP
O	907	908	-	-	HYPH	B-NP
O	908	917	dependent	dependent	JJ	I-NP
O	917	918	,	,	,	I-NP
O	919	922	p21	p21	NN	I-NP
O	922	923	-	-	HYPH	I-NP
O	923	932	activated	activate	VBN	B-VP
O	933	939	kinase	kinase	NN	B-NP
O	940	941	1	1	CD	I-NP
O	942	943	(	(	(	O
O	943	946	PAK	PAK	NN	B-NP
O	946	947	-	-	HYPH	O
O	947	948	1	1	CD	O
O	948	949	)	)	)	O
O	950	958	activity	activity	NN	B-NP
O	958	959	.	.	.	O

O	960	962	We	We	PRP	B-NP
O	963	967	show	show	VBP	B-VP
O	968	972	that	that	IN	B-SBAR
O	973	977	PSMA	PSMA	NN	B-NP
O	978	988	inhibition	inhibition	NN	I-NP
O	988	989	,	,	,	O
O	990	999	knockdown	knockdown	NN	B-NP
O	999	1000	,	,	,	O
O	1001	1003	or	or	CC	O
O	1004	1014	deficiency	deficiency	NN	B-NP
O	1015	1024	decreases	decrease	VBZ	B-VP
B-Cell	1025	1036	endothelial	endothelial	JJ	B-NP
I-Cell	1037	1041	cell	cell	NN	I-NP
O	1042	1050	invasion	invasion	NN	I-NP
O	1051	1053	in	in	FW	B-ADVP
O	1054	1059	vitro	vitro	FW	I-ADVP
O	1060	1063	via	via	IN	B-PP
O	1064	1072	integrin	integrin	NN	B-NP
O	1073	1076	and	and	CC	I-NP
O	1077	1080	PAK	PAK	NN	I-NP
O	1080	1081	,	,	,	O
O	1082	1086	thus	thus	RB	B-ADVP
O	1087	1097	abrogating	abrogate	VBG	B-VP
O	1098	1110	angiogenesis	angiogenesis	NN	B-NP
O	1110	1111	.	.	.	O

O	1112	1125	Interestingly	Interestingly	RB	B-ADVP
O	1125	1126	,	,	,	O
O	1127	1130	the	the	DT	B-NP
O	1131	1145	neutralization	neutralization	NN	I-NP
O	1146	1148	of	of	IN	B-PP
O	1149	1153	beta	beta	NN	B-NP
O	1153	1154	(	(	(	O
O	1154	1155	1	1	CD	B-NP
O	1155	1156	)	)	)	O
O	1157	1159	or	or	CC	O
O	1160	1163	the	the	DT	B-NP
O	1164	1176	inactivation	inactivation	NN	I-NP
O	1177	1179	of	of	IN	B-PP
O	1180	1183	PAK	PAK	NN	B-NP
O	1184	1193	increases	increase	VBZ	B-VP
O	1194	1198	PSMA	PSMA	NN	B-NP
O	1199	1207	activity	activity	NN	I-NP
O	1207	1208	,	,	,	O
O	1209	1219	suggesting	suggest	VBG	B-VP
O	1220	1224	that	that	IN	B-SBAR
O	1225	1229	they	they	PRP	B-NP
O	1230	1240	negatively	negatively	RB	B-ADVP
O	1241	1249	regulate	regulate	VBP	B-VP
O	1250	1254	PSMA	PSMA	NN	B-NP
O	1254	1255	.	.	.	O

O	1256	1260	This	This	DT	B-NP
O	1261	1269	negative	negative	JJ	I-NP
O	1270	1280	regulation	regulation	NN	I-NP
O	1281	1283	is	be	VBZ	B-VP
O	1284	1292	mediated	mediate	VBN	I-VP
O	1293	1295	by	by	IN	B-PP
O	1296	1299	the	the	DT	B-NP
B-Cellular_component	1300	1312	cytoskeleton	cytoskeleton	NN	I-NP
O	1313	1315	as	as	IN	B-PP
O	1316	1319	the	the	DT	B-NP
O	1320	1330	disruption	disruption	NN	I-NP
O	1331	1333	of	of	IN	B-PP
O	1334	1346	interactions	interaction	NNS	B-NP
O	1347	1354	between	between	IN	B-PP
O	1355	1358	the	the	DT	B-NP
O	1359	1363	PSMA	PSMA	NN	I-NP
B-Organism_substance	1364	1375	cytoplasmic	cytoplasmic	JJ	I-NP
O	1376	1380	tail	tail	NN	I-NP
O	1381	1384	and	and	CC	O
O	1385	1388	the	the	DT	B-NP
O	1389	1395	anchor	anchor	NN	I-NP
O	1396	1403	protein	protein	NN	I-NP
O	1404	1411	filamin	filamin	NN	I-NP
O	1412	1413	A	A	NN	I-NP
O	1414	1423	decreases	decrease	VBZ	B-VP
O	1424	1428	PSMA	PSMA	NN	B-NP
O	1429	1437	activity	activity	NN	I-NP
O	1437	1438	,	,	,	O
O	1439	1447	integrin	integrin	NN	B-NP
O	1448	1456	function	function	NN	I-NP
O	1456	1457	,	,	,	O
O	1458	1461	and	and	CC	O
O	1462	1465	PAK	PAK	NN	B-NP
O	1466	1476	activation	activation	NN	I-NP
O	1476	1477	.	.	.	O

O	1478	1485	Finally	Finally	RB	B-ADVP
O	1485	1486	,	,	,	O
O	1487	1490	the	the	DT	B-NP
O	1491	1501	inhibition	inhibition	NN	I-NP
O	1502	1504	of	of	IN	B-PP
O	1505	1508	PAK	PAK	NN	B-NP
O	1509	1519	activation	activation	NN	I-NP
O	1520	1528	enhances	enhance	VBZ	B-VP
O	1529	1532	the	the	DT	B-NP
O	1533	1537	PSMA	PSMA	NN	I-NP
O	1537	1538	/	/	SYM	B-NP
O	1538	1545	filamin	filamin	NN	I-NP
O	1546	1547	A	A	NN	I-NP
O	1548	1559	interaction	interaction	NN	I-NP
O	1560	1563	and	and	CC	O
O	1563	1564	,	,	,	O
O	1565	1569	thus	thus	RB	B-ADVP
O	1569	1570	,	,	,	O
O	1571	1577	boosts	boost	VBZ	B-VP
O	1578	1582	PSMA	PSMA	NN	B-NP
O	1583	1591	activity	activity	NN	I-NP
O	1591	1592	.	.	.	O

O	1593	1598	These	These	DT	B-NP
O	1599	1603	data	datum	NNS	I-NP
O	1604	1609	imply	imply	VBP	B-VP
O	1610	1614	that	that	IN	B-SBAR
O	1615	1619	PSMA	PSMA	NN	B-NP
O	1620	1632	participates	participate	VBZ	B-VP
O	1633	1635	in	in	IN	B-PP
O	1636	1638	an	an	DT	B-NP
O	1639	1653	autoregulatory	autoregulatory	JJ	I-NP
O	1654	1658	loop	loop	NN	I-NP
O	1658	1659	,	,	,	O
O	1660	1667	wherein	wherein	IN	B-PP
O	1668	1674	active	active	JJ	B-NP
O	1675	1679	PSMA	PSMA	NN	I-NP
O	1680	1691	facilitates	facilitate	VBZ	B-VP
O	1692	1700	integrin	integrin	NN	B-NP
O	1701	1710	signaling	signaling	NN	I-NP
O	1711	1714	and	and	CC	O
O	1715	1718	PAK	PAK	NN	B-NP
O	1719	1729	activation	activation	NN	I-NP
O	1729	1730	,	,	,	O
O	1731	1738	leading	lead	VBG	B-VP
O	1739	1741	to	to	TO	B-PP
O	1742	1746	both	both	CC	O
O	1747	1757	productive	productive	JJ	B-NP
O	1758	1766	invasion	invasion	NN	I-NP
O	1767	1770	and	and	CC	I-NP
O	1771	1785	downregulation	downregulation	NN	I-NP
O	1786	1788	of	of	IN	B-PP
O	1789	1797	integrin	integrin	NN	B-NP
O	1798	1802	beta	beta	NN	I-NP
O	1802	1803	(	(	(	O
O	1803	1804	1	1	CD	B-NP
O	1804	1805	)	)	)	O
O	1806	1815	signaling	signaling	NN	B-NP
O	1816	1819	via	via	IN	B-PP
O	1820	1827	reduced	reduce	VBN	B-NP
O	1828	1832	PSMA	PSMA	NN	I-NP
O	1833	1841	activity	activity	NN	I-NP
O	1841	1842	.	.	.	O

O	1843	1852	Therefore	Therefore	RB	B-ADVP
O	1852	1853	,	,	,	O
O	1854	1856	we	we	PRP	B-NP
O	1857	1861	have	have	VBP	B-VP
O	1862	1872	identified	identify	VBN	I-VP
O	1873	1874	a	a	DT	B-NP
O	1875	1880	novel	novel	JJ	I-NP
O	1881	1885	role	role	NN	I-NP
O	1886	1889	for	for	IN	B-PP
O	1890	1894	PSMA	PSMA	NN	B-NP
O	1895	1897	as	as	IN	B-PP
O	1898	1899	a	a	DT	B-NP
O	1900	1904	true	true	JJ	I-NP
O	1905	1914	molecular	molecular	JJ	I-NP
O	1915	1924	interface	interface	NN	I-NP
O	1924	1925	,	,	,	O
O	1926	1937	integrating	integrate	VBG	B-VP
O	1938	1942	both	both	CC	O
B-Immaterial_anatomical_entity	1943	1956	extracellular	extracellular	JJ	B-NP
O	1957	1960	and	and	CC	I-NP
B-Immaterial_anatomical_entity	1961	1974	intracellular	intracellular	JJ	I-NP
O	1975	1982	signals	signal	NNS	I-NP
O	1983	1989	during	during	IN	B-PP
O	1990	2002	angiogenesis	angiogenesis	NN	B-NP
O	2002	2003	.	.	.	O

